LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession

Go back to LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession
(NASDAQ: LENZ) Delayed: 3.39 +0.18 (5.61%)
Previous Close $3.21    52 Week High $ 
Open $3.00    52 Week Low $ 
Day High $3.56    P/E N/A 
Day Low $3.00    EPS $ 
Volume 3,502,268